Savara Inc.
Support and Resistance Levels
Past performance
News About SVRA
All events for SVRA
All deals for SVRA
Financial Ratios
Financial Statements
SVRA vs Sector & Peers
About Savara Inc.
Savara Inc. is a biopharmaceutical firm in the clinical development phase, specializing in therapies for uncommon respiratory conditions. Their primary investigational drug, molgramostim, is an inhaled form of granulocyte-macrophage colony-stimulating factor (GM-CSF). This compound is currently undergoing Phase III trials to address autoimmune pulmonary alveolar proteinosis. The company's main operations are situated in Austin, Texas. Website savarapharma.com
Headquarters Yardley, PA, US